A common TMPRSS2 variant has a protective effect against severe COVID-19
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A common TMPRSS2 variant has a protective effect against severe COVID-19
Authors
Keywords
SARS-CoV-2, COVID-19, TMPRSS2, Targeting the host to prevent COVID19 severity
Journal
Current Research in Translational Medicine
Volume 70, Issue 2, Pages 103333
Publisher
Elsevier BV
Online
2022-01-10
DOI
10.1016/j.retram.2022.103333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site
- (2021) Anna Z Mykytyn et al. eLife
- Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
- (2021) Fei Li et al. Nature Communications
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
- (2021) Markus Hoffmann et al. EBioMedicine
- Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
- (2021) Yasser Sakr et al. INTENSIVE CARE MEDICINE
- The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- (2021) Thomas P. Peacock et al. Nature Microbiology
- Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19
- (2021) Maria Monticelli et al. European Journal of Medical Genetics
- Highly accurate protein structure prediction with AlphaFold
- (2021) John Jumper et al. NATURE
- Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
- (2021) Pratha Sah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age
- (2020) Katarzyna Bilinska et al. ACS Chemical Neuroscience
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- SARS ‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells
- (2020) Soeren Lukassen et al. EMBO JOURNAL
- First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations
- (2020) Alireza Paniri et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
- (2020) Zhaohai Zheng et al. JOURNAL OF INFECTION
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
- (2020) Yuan Hou et al. BMC Medicine
- Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human
- (2020) Sabyasachi Senapati et al. JOURNAL OF GENETICS
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
- (2020) Paul F. McKay et al. Nature Communications
- Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis
- (2020) Bing-Bing Wu et al. INFECTION GENETICS AND EVOLUTION
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety
- (2020) Peter Breining et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium
- (2020) Bryce A. Schuler et al. JOURNAL OF CLINICAL INVESTIGATION
- Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy
- (2020) Aleksei Zarubin et al. Genes
- Can Predicted Protein 3D Structures Provide Reliable Insights into whether Missense Variants Are Disease Associated?
- (2019) Sirawit Ittisoponpisan et al. JOURNAL OF MOLECULAR BIOLOGY
- TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes
- (2019) Hannah Limburg et al. JOURNAL OF VIROLOGY
- Survey of Human Chromosome 21 Gene Expression Effects on Early Development in Danio rerio
- (2018) Sarah Edie et al. G3-Genes Genomes Genetics
- Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies
- (2018) Wei Zhou et al. NATURE GENETICS
- UniProt: the universal protein knowledgebase
- (2016) NUCLEIC ACIDS RESEARCH
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- The Phyre2 web portal for protein modeling, prediction and analysis
- (2015) Lawrence A Kelley et al. Nature Protocols
- SIFT missense predictions for genomes
- (2015) Robert Vaser et al. Nature Protocols
- TMPRSS2, a novel membrane-anchored mediator in cancer pain
- (2015) David K. Lam et al. PAIN
- Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
- (2014) Claudia Giambartolomei et al. PLoS Genetics
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
- (2012) M. Kawase et al. JOURNAL OF VIROLOGY
- Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, Condel
- (2011) Abel González-Pérez et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- METAL: fast and efficient meta-analysis of genomewide association scans
- (2010) C. J. Willer et al. BIOINFORMATICS
- A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
- (2010) A. Shulla et al. JOURNAL OF VIROLOGY
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More